Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Circulation
    October 2017
  1. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    >> Share

  2. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    >> Share

    September 2017
  3. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    >> Share

  4. NIIRANEN TJ, Larson MG, McCabe EL, Xanthakis V, et al
    Prognosis of Prehypertension Without Progression to Hypertension.
    Circulation. 2017;136:1262-1264.
    >> Share

  5. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    >> Share

  6. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    >> Share

  7. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    >> Share

  8. HUANG C, Moran AE, Coxson PG, Yang X, et al
    Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.
    Circulation. 2017 Sep 7. pii: CIRCULATIONAHA.116.026487.
    >> Share

    August 2017
  9. LI H, Cai J, Chen R, Zhao Z, et al
    Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification.
    Circulation. 2017;136:618-627.
    >> Share

  10. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    >> Share


  11. Correction to: Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Circulation. 2017;136:e136.
    >> Share

    July 2017
  12. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    >> Share

    June 2017
  13. STERGIOU GS, Ntineri A, Kollias A
    Defining Ambulatory Blood Pressure Thresholds for Decision Making in Hypertension: The Effect of Race and Methodology.
    Circulation. 2017;135:2481-2484.
    >> Share

  14. RAVENELL J, Shimbo D, Booth JN 3rd, Sarpong DF, et al
    Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Circulation. 2017;135:2470-2480.
    >> Share

  15. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    >> Share

  16. MCEVOY JW, Blaha MJ
    Response by McEvoy and Blaha to Letter Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1113-e1114.
    >> Share

  17. HARBAOUI B, Courand PY, Lantelme P
    Letter by Harbaoui et al Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1111-e1112.
    >> Share

    May 2017
  18. SAG CM, Schnelle M, Zhang J, Murdoch CE, et al
    Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
    Circulation. 2017;135:2163-2177.
    >> Share

  19. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    >> Share

  20. SOLIMAN EZ, Ambrosius WT, Cushman WC, Zhang ZM, et al
    Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial.
    Circulation. 2017 May 16. pii: CIRCULATIONAHA.117.028441.
    >> Share

    April 2017
  21. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    >> Share

  22. PHILLIPS RA
    Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).
    Circulation. 2017;135:1629-1631.
    >> Share

  23. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    >> Share

  24. BOYD HA, Basit S, Behrens I, Leirgul E, et al
    Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.
    Circulation. 2017 Apr 19. pii: CIRCULATIONAHA.116.024600.
    >> Share

    March 2017
  25. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    >> Share

  26. CAILLON A, Mian MO, Fraulob-Aquino JC, Huo KG, et al
    Gamma Delta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Circulation. 2017 Mar 22. pii: CIRCULATIONAHA.116.027058.
    >> Share

  27. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    >> Share

    February 2017
  28. CHEN J, Sysol JR, Singla S, Zhao S, et al
    Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and is a Therapeutic Target in Pulmonary Arterial Hypertension.
    Circulation. 2017 Feb 15. pii: CIRCULATIONAHA.116.024557.
    >> Share

    January 2017
  29. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    >> Share

  30. WHELTON SP, Blumenthal RS
    Beyond the Headlines: Insights on Potassium Supplementation for the Treatment of Hypertension From the Canadian Hypertension Education Program Guidelines (CHEP).
    Circulation. 2017;135:3-4.
    >> Share

  31. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    >> Share

    December 2016
  32. INAMI T, Kataoka M, Yanagisawa R, Ishiguro H, et al
    Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2016;134:2030-2032.
    >> Share

  33. MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
    High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
    >> Share

  34. WILLIAMS B
    Time to Abandon Clinic Blood Pressure for the Diagnosis of Hypertension?
    Circulation. 2016;134:1808-1811.
    >> Share

  35. SCHWARTZ JE, Burg MM, Shimbo D, Broderick JE, et al
    Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population: Results From the Masked Hypertension Study.
    Circulation. 2016;134:1794-1807.
    >> Share

    November 2016
  36. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    >> Share

  37. RHODES CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, et al
    Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602.
    >> Share

  38. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    >> Share

  39. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    >> Share

  40. ST-ONGE MP, Grandner MA, Brown D, Conroy MB, et al
    Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e367-e386.
    >> Share

    October 2016
  41. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    >> Share

    September 2016
  42. MONTANIEL KR, Harrison DG
    Is Hypertension a Bone Marrow Disease?
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.116.024520.
    >> Share

  43. WANG L, Zhao XC, Cui W, Ma YQ, et al
    Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.115.020754.
    >> Share


  44. Correction to: Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension.
    Circulation. 2016;134:e260.
    >> Share

  45. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    >> Share

  46. OPARIL S, Lewis CE
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to < 120/80 mmHg Target?: A Protagonist View from SPRINT.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023263.
    >> Share

    August 2016
  47. AZIZI M, Pereira H, Hamdidouche I, Gosse P, et al
    Adherence to Antihypertensive Treatment and the Blood Pressure Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.022922.
    >> Share

  48. CALHOUN DA
    Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024385.
    >> Share

  49. VAN DER BRUGGEN CE, Happe CM, Goumans MJ, Bogaard HJ, et al
    Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e117-8.
    >> Share

  50. KATAOKA M, Satoh T, Fukuda K
    Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e115-6.
    >> Share

  51. LI M, Riddle S, Zhang H, D'Alessandro A, et al
    Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Co-Repressor C-terminal Binding Protein-1.
    Circulation. 2016 Aug 25. pii: CIRCULATIONAHA.116.023171.
    >> Share

  52. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    >> Share

  53. LI H, Zhang X, Wang F, Zhou L, et al
    MiR-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats By Up-Regulating Mitochondrial Translation.
    Circulation. 2016 Aug 19. pii: CIRCULATIONAHA.116.023926.
    >> Share

  54. LAI YC, Gladwin MT
    Response by Lai and Gladwin to Letter Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractio
    Circulation. 2016;134:e79-80.
    >> Share

  55. CARLSTROM M, Lundberg JO
    Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;134:e77-8.
    >> Share

  56. MORAN AE
    Still on the Road to Worldwide Hypertension Control.
    Circulation. 2016;134:451-4.
    >> Share

  57. MILLS KT, Bundy JD, Kelly TN, Reed JE, et al
    Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.
    Circulation. 2016;134:441-50.
    >> Share

  58. O'GARA PT
    Management of Hypertension in Patients with Mild-to-Moderate Aortic Stenosis: Navigating the SEAS.
    Circulation. 2016 Aug 2. pii: CIRCULATIONAHA.116.023688.
    >> Share

  59. NIELSEN OW, Sajadieh A, Sabbah M, Greve AM, et al
    Assessing Optimal Blood Pressure in Patients with Asymptomatic Aortic Valve Stenosis: The SEAS Study.
    Circulation. 2016 Aug 2. pii: CIRCULATIONAHA.115.021213.
    >> Share

    July 2016
  60. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    >> Share

  61. BHATT DL, Gersh BJ
    Ruminations About Renal Denervation.
    Circulation. 2016;134:267-9.
    >> Share

    May 2016
  62. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e662.
    >> Share

  63. NIKPOUR M, Prior D, Celermajer D
    Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e661.
    >> Share

  64. FUJIMOTO T, Morofuji Y, Horie N, Izumo T, et al
    One Cause of Secondary Hypertension: Neurogenic Etiology.
    Circulation. 2016;133:1985-6.
    >> Share

  65. HSU S, Houston BA, Tampakakis E, Bacher AC, et al
    Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.022082.
    >> Share

  66. MARON BA
    Independence Day: Separating Right Ventricular Function from Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.023237.
    >> Share

    April 2016
  67. DAI Z, Li M, Wharton J, Zhu MM, et al
    PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans through HIF-2alpha.
    Circulation. 2016 Apr 25. pii: CIRCULATIONAHA.116.021494.
    >> Share

  68. BAUDRAND R, Pojoga L, Vaidya A, Garza A, et al
    Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation. 2016;133:e606.
    >> Share

  69. CAMPBELL DJ
    Letter by Campbell Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation. 2016;133:e605.
    >> Share

  70. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    >> Share

  71. HOEPER MM
    Residual Pulmonary Hypertension After Pulmonary Endarterectomy: The Fog is Clearing.
    Circulation. 2016 Apr 6. pii: CIRCULATIONAHA.116.022595.
    >> Share


  72. ECG Response: April 5, 2016.
    Circulation. 2016;133:1419-20.
    >> Share

  73. ARANY Z, Elkayam U
    Peripartum Cardiomyopathy.
    Circulation. 2016;133:1397-409.
    >> Share

  74. HOPPER RK, Moonen JA, Diebold I, Cao A, et al
    In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and its Target Slug.
    Circulation. 2016 Apr 4. pii: CIRCULATIONAHA.115.020617.
    >> Share

    March 2016
  75. BRITTAIN EL, Talati M, Fessel JP, Zhu H, et al
    Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.019351.
    >> Share

  76. CHIU P, Irons M, van de Rijn M, Liang DH, et al
    Giant Pulmonary Artery Aneurysm in a Patient With Marfan Syndrome and Pulmonary Hypertension.
    Circulation. 2016;133:1218-21.
    >> Share


  77. ECG Response: March 22, 2016.
    Circulation. 2016;133:1217.
    >> Share

  78. VAN DER BRUGGEN CE, Happe CM, Dorfmuller P, Trip P, et al
    Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    Circulation. 2016 Mar 16. pii: CIRCULATIONAHA.115.020696.
    >> Share

  79. HUBERS SA, Brown NJ
    Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Circulation. 2016;133:1115-24.
    >> Share

  80. KOENE RJ, Prizment AE, Blaes A, Konety SH, et al
    Shared Risk Factors in Cardiovascular Disease and Cancer.
    Circulation. 2016;133:1104-14.
    >> Share

  81. LUFT FC
    11-beta Hydroxysteroid Dehydrogenase-2 and Salt-Sensitive Hypertension.
    Circulation. 2016 Mar 7. pii: CIRCULATIONAHA.116.022038.
    >> Share

  82. EVANS LC, Ivy JR, Wyrwoll C, McNairn JA, et al
    Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.
    Circulation. 2016 Mar 7. pii: CIRCULATIONAHA.115.019341.
    >> Share

  83. HALL JE
    Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension.
    Circulation. 2016;133:894-906.
    >> Share

  84. MORRIS RC JR, Schmidlin O, Sebastian A, Tanaka M, et al
    Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.
    Circulation. 2016;133:881-93.
    >> Share

  85. MORRIS RC JR, Schmidlin O, Sebastian A, Tanaka M, et al
    Response to Hall.
    Circulation. 2016;133:907.
    >> Share

    February 2016
  86. ANTIGNY F, Hautefort A, Meloche J, Belacel-Ouari M, et al
    Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2016 Feb 24. pii: CIRCULATIONAHA.115.020951.
    >> Share

  87. SCHWALM JD, McKee M, Huffman MD, Yusuf S, et al
    Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.
    Circulation. 2016;133:742-55.
    >> Share

  88. MARON BA, Hess E, Maddox TM, Opotowsky AR, et al
    Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the VA-CART Program.
    Circulation. 2016 Feb 12. pii: CIRCULATIONAHA.115.020207.
    >> Share

  89. BOBROW K, Farmer AJ, Springer D, Shanyinde M, et al
    Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial.
    Circulation. 2016;133:592-600.
    >> Share

  90. LAUFFENBURGER JC, Choudhry NK
    Text Messaging and Patient Engagement in an Increasingly Mobile World.
    Circulation. 2016;133:555-6.
    >> Share

    January 2016
  91. DELCROIX M, Lang I, Pepke-Zaba J, Jansa P, et al
    Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry.
    Circulation. 2016 Jan 29. pii: CIRCULATIONAHA.115.016522.
    >> Share

  92. LAI YC, Tabima DM, Dube JJ, Hughan KS, et al
    SIRT3-AMPK Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018935.
    >> Share

  93. RIBEIRO AL, Duncan BB, Brant LC, Lotufo PA, et al
    Cardiovascular Health in Brazil: Trends and Perspectives.
    Circulation. 2016;133:422-33.
    >> Share

  94. ZHONG J, Cayir A, Trevisi L, Sanchez-Guerra M, et al
    Traffic-Related Air Pollution, Blood Pressure, and Adaptive Response of Mitochondrial Abundance.
    Circulation. 2016;133:378-87.
    >> Share

  95. BASU S, Yudkin JS, Sussman J, Millett C, et al
    Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target-Versus Risk-Based Blood Pressure Treatment.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.019985.
    >> Share

    December 2015
  96. DANIELS SR
    How to Define Hypertension in Children and Adolescents.
    Circulation. 2015 Dec 15. pii: CIRCULATIONAHA.115.020531.
    >> Share

  97. BLACK HR, Sica D, Ferdinand K, White WB, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Circulation. 2015;132:e298-302.
    >> Share

  98. WAXMAN AB, Farber HW
    Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
    Circulation. 2015;132:2152-61.
    >> Share

    November 2015
  99. ANDERSSON C, Vasan RS
    Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far?
    Circulation. 2015;132:1783-5.
    >> Share

  100. GUAN J, Khambhati J, Jones LW, Morgans A, et al
    Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.
    Circulation. 2015;132:e218-20.
    >> Share

  101. WATANABE Y, Miyata T, Tanemoto K
    Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.
    Circulation. 2015;132:1701-9.
    >> Share

    October 2015
  102. KIM JB, Kim K, Lindsay ME, MacGillivray T, et al
    Risk of rupture or dissection in descending thoracic aortic aneurysm.
    Circulation. 2015;132:1620-9.
    >> Share

    September 2015
  103. ROTH GA, Nguyen G, Forouzanfar MH, Mokdad AH, et al
    Estimates of Global and Regional Premature Cardiovascular Mortality in 2025.
    Circulation. 2015;132:1270-82.
    >> Share

  104. CIRILLO PM, Cohn BA
    Pregnancy Complications and Cardiovascular Disease Death: Fifty-Year Follow-Up of the Child Health and Development Studies Pregnancy Cohort.
    Circulation. 2015 Sep 21. pii: CIRCULATIONAHA.113.003901.
    >> Share

  105. SHAH AM, Claggett B, Folsom AR, Lutsey PL, et al
    Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly.
    Circulation. 2015 Sep 8. pii: CIRCULATIONAHA.115.017882.
    >> Share

  106. ASHRAFIAN H, Pal N, Sivaswamy N, Mahmod M, et al
    The Effect of Selective Heart Rate Slowing in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2015 Sep 2. pii: CIRCULATIONAHA.115.017119.
    >> Share

    August 2015
  107. ABRAHAM TM, Pedley A, Massaro JM, Hoffman U, et al
    Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors.
    Circulation. 2015 Aug 20. pii: CIRCULATIONAHA.114.015000.
    >> Share

  108. GOLDSTEIN BI, Carnethon MR, Matthews KA, McIntyre RS, et al
    Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Aug 10. pii: CIR.0000000000000229.
    >> Share

  109. HAVRANEK EP, Mujahid MS, Barr DA, Blair IV, et al
    Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Aug 3. pii: CIR.0000000000000228.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016